Form D — Cascade Biocatalysts, Inc.
0001231919-25-000162 · filed 2025-08-25
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $5,616,959
- Total sold
- $5,441,785
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cascade Biocatalysts, Inc.
- CIK
- 2083126
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 3960 NIAGARA STREET
DENVER, CO 80207 - Phone
- (310) 913-0576
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alexander Rosay · Executive OfficerDenver, CO Find on LinkedIn ↗
-
James Weltz · Executive OfficerDenver, CO Find on LinkedIn ↗
-
Jared Campbell · DirectorDenver, CO Find on LinkedIn ↗
View original on SEC EDGAR.